Novo Nordisk
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
CEOLars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees76,302
Employees76,302
HeadquartersBagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded1931
Founded1931
Employees76,302
Employees76,302
NVO Key Statistics
Market cap224.78B
Market cap224.78B
Price-Earnings ratio15.97
Price-Earnings ratio15.97
Dividend yield2.19%
Dividend yield2.19%
Average volume18.73M
Average volume18.73M
High today$52.34
High today$52.34
Low today$52.01
Low today$52.01
Open price$53.97
Open price$53.97
Volume1.63M
Volume1.63M
52 Week high$139.74
52 Week high$139.74
52 Week low$52.01
52 Week low$52.01
NVO News
Seeking Alpha 50m
Novo Nordisk continues to slip after outlook cut, obesity drug worriesNovo Nordisk (NVO) continued its downward spiral and fell 3.8% in premarket trade, a day after the Danish drugmaker slashed its full-year outlook, weighed down...
NPR 16h
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding - NPR...
CNBC 1d
Novo Nordisk shares plunge 15% after Wegovy-maker cuts full-year guidanceMedical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Danish pharmaceutical giant Novo Nordisk on Tuesday...
Analyst ratings
56%
of 32 ratingsBuy
56.3%
Hold
34.4%
Sell
9.4%